Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Other financing activities (2019 - 2026)

Geron's (GERN) quarterly Other financing activities came in at $473000.0 in Q2 2026, down 19.97% year-over-year from $591000.0 in Q2 2025, and down 68.7% quarter-over-quarter from $1.5 million in Q1 2026.

Analysis

Geron (GERN) Other financing activities (2019 - 2026) Analysis & Trends

Geron has disclosed Other financing activities across 8 years of filings, most recently posting $473000.0 for Q2 2026.

  • In Q2 2026, Other financing activities fell 19.97% year-over-year to $473000.0; the TTM figure through Jun 2026 stood at $3.4 million (down 96.57% YoY), while the FY2025 annual figure was $2.3 million, down 98.19% from the prior year.
  • Other financing activities came in at $473000.0 for Q2 2026 at Geron, down from $1.5 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $98.3 million in Q4 2024 to a low of $4000.0 in Q3 2024.
  • Average Other financing activities over 5 years is $15.3 million, with a median of $1.5 million recorded in 2026.
  • Year-over-year, Other financing activities sank 99.99% in 2024 and surged 13450.0% in 2025.
  • Over 5 years, Other financing activities stood at $11.5 million in 2022, then jumped by 145.64% to $28.3 million in 2023, then surged by 247.25% to $98.3 million in 2024, then sank by 99.11% to $878000.0 in 2025, then sank by 46.13% to $473000.0 in 2026.
  • Per Business Quant data, the three most recent Other financing activities figures were $473000.0 in Q2 2026, $1.5 million in Q1 2026, and $878000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Geron 914.60 Mn 613.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 473,000.00
Mar 31, 2026 1.51 Mn
Dec 31, 2025 878,000.00
Sep 30, 2025 542,000.00
Jun 30, 2025 591,000.00
Mar 31, 2025 256,000.00
Dec 31, 2024 98.30 Mn
Sep 30, 2024 4,000.00
Jun 30, 2024 365,000.00
Mar 31, 2024 6.75 Mn
Sep 30, 2023 28.31 Mn
Jun 30, 2023 17.77 Mn
Mar 31, 2023 59.84 Mn
Dec 31, 2022 11.53 Mn
Sep 30, 2022 2.88 Mn
Jun 30, 2021 2.46 Mn
Mar 31, 2021 17,000.00
Dec 31, 2020 111,000.00
Sep 30, 2020 16,000.00
Dec 31, 2019 37,000.00